Hamilton James C's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Jan 17, 2024
- Accession no.
- 0001628280-24-001576
- Filed
- Jan 17, 2024
- Trade date
- Jan 12, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $292.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hamilton James CCIK 0001830755 | Officer (Chief Discovery/Trans Medicine) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Common Stock | SSaleDisposed | −4,238 | $36.47 | −$154,559.86 | 214,553 | Direct | |
| Jan 12, 2024 | Common Stock | SSaleDisposed | −3,702 | $37.37 | −$138,343.74 | 210,851 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.